286 related articles for article (PubMed ID: 38539439)
1. A-Z of Epigenetic Readers: Targeting Alternative Splicing and Histone Modification Variants in Cancer.
Mohan N; Dashwood RH; Rajendran P
Cancers (Basel); 2024 Mar; 16(6):. PubMed ID: 38539439
[TBL] [Abstract][Full Text] [Related]
2. Regulation of alternative splicing: Functional interplay with epigenetic modifications and its implication to cancer.
Wang N; Hu Y; Wang Z
Wiley Interdiscip Rev RNA; 2023 Sep; ():e1815. PubMed ID: 37697868
[TBL] [Abstract][Full Text] [Related]
3. Alternative Splicing, Epigenetic Modifications and Cancer: A Dangerous Triangle, or a Hopeful One?
Gimeno-Valiente F; López-Rodas G; Castillo J; Franco L
Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158828
[TBL] [Abstract][Full Text] [Related]
4. Histone Marks-Dependent Effect on Alternative Splicing: New Perspectives for Targeted Splicing Modulation in Cancer?
Imbriano C; Belluti S
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955433
[TBL] [Abstract][Full Text] [Related]
5. [The epigenetic effect on pre-mRNA alternative splicing].
Zhao J; Wang F; Xu Z; Fan Y
Yi Chuan; 2014 Mar; 36(3):248-55. PubMed ID: 24846965
[TBL] [Abstract][Full Text] [Related]
6. Histone modifications are associated with transcript isoform diversity in normal and cancer cells.
Podlaha O; De S; Gonen M; Michor F
PLoS Comput Biol; 2014 Jun; 10(6):e1003611. PubMed ID: 24901363
[TBL] [Abstract][Full Text] [Related]
7. Potential epigenomic co-management in rare diseases and epigenetic therapy.
Nguyen KV
Nucleosides Nucleotides Nucleic Acids; 2019; 38(10):752-780. PubMed ID: 31079569
[TBL] [Abstract][Full Text] [Related]
8. Alternative splicing links histone modifications to stem cell fate decision.
Xu Y; Zhao W; Olson SD; Prabhakara KS; Zhou X
Genome Biol; 2018 Sep; 19(1):133. PubMed ID: 30217220
[TBL] [Abstract][Full Text] [Related]
9. Rebelled epigenome: histone H3S10 phosphorylation and H3S10 kinases in cancer biology and therapy.
Komar D; Juszczynski P
Clin Epigenetics; 2020 Oct; 12(1):147. PubMed ID: 33054831
[TBL] [Abstract][Full Text] [Related]
10. We skip to work: alternative splicing in normal and malignant myelopoiesis.
Wong ACH; Rasko JEJ; Wong JJ
Leukemia; 2018 May; 32(5):1081-1093. PubMed ID: 29467484
[TBL] [Abstract][Full Text] [Related]
11. The potential role of a retrotransposed gene and a long noncoding RNA in regulating an X-linked chromatin gene (KDM5C): Novel epigenetic mechanism in autism.
Talebizadeh Z; Shah A; DiTacchio L
Autism Res; 2019 Jul; 12(7):1007-1021. PubMed ID: 31087518
[TBL] [Abstract][Full Text] [Related]
12. Interplay between different epigenetic modifications and mechanisms.
Murr R
Adv Genet; 2010; 70():101-41. PubMed ID: 20920747
[TBL] [Abstract][Full Text] [Related]
13. Regulation of alternative splicing by local histone modifications: potential roles for RNA-guided mechanisms.
Zhou HL; Luo G; Wise JA; Lou H
Nucleic Acids Res; 2014 Jan; 42(2):701-13. PubMed ID: 24081581
[TBL] [Abstract][Full Text] [Related]
14. The Crosstalk Between Epigenetic Mechanisms and Alternative RNA Processing Regulation.
Zhang J; Zhang YZ; Jiang J; Duan CG
Front Genet; 2020; 11():998. PubMed ID: 32973889
[TBL] [Abstract][Full Text] [Related]
15. The functional modulation of epigenetic regulators by alternative splicing.
Lois S; Blanco N; Martínez-Balbás M; de la Cruz X
BMC Genomics; 2007 Jul; 8():252. PubMed ID: 17651478
[TBL] [Abstract][Full Text] [Related]
16. A saga of cancer epigenetics: linking epigenetics to alternative splicing.
Narayanan SP; Singh S; Shukla S
Biochem J; 2017 Mar; 474(6):885-896. PubMed ID: 28270561
[TBL] [Abstract][Full Text] [Related]
17. Epigenetics in alternative pre-mRNA splicing.
Luco RF; Allo M; Schor IE; Kornblihtt AR; Misteli T
Cell; 2011 Jan; 144(1):16-26. PubMed ID: 21215366
[TBL] [Abstract][Full Text] [Related]
18. Histone and RNA-binding protein interaction creates crosstalk network for regulation of alternative splicing.
Kim YE; Park C; Kim KE; Kim KK
Biochem Biophys Res Commun; 2018 Apr; 499(1):30-36. PubMed ID: 29551686
[TBL] [Abstract][Full Text] [Related]
19. Histone H2A.Z deregulation in prostate cancer. Cause or effect?
Dryhurst D; Ausió J
Cancer Metastasis Rev; 2014 Sep; 33(2-3):429-39. PubMed ID: 24398858
[TBL] [Abstract][Full Text] [Related]
20. An apicomplexan bromodomain protein, TgBDP1, associates with diverse epigenetic factors to regulate essential transcriptional processes in
Fleck K; McNutt S; Chu F; Jeffers V
mBio; 2023 Aug; 14(4):e0357322. PubMed ID: 37350586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
